156 related articles for article (PubMed ID: 30564368)
1. MDM2 inhibitor ameliorates cisplatin-induced nephropathy via NFκΒ signal inhibition.
Fujikura T; Yasuda H; Iwakura T; Tsuji T; Anders HJ
Pharmacol Res Perspect; 2019 Feb; 7(1):e00450. PubMed ID: 30564368
[TBL] [Abstract][Full Text] [Related]
2. MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice.
Mulay SR; Thomasova D; Ryu M; Anders HJ
Kidney Int; 2012 Jun; 81(12):1199-211. PubMed ID: 22297670
[TBL] [Abstract][Full Text] [Related]
3. Protein extracted from Porphyra yezoensis prevents cisplatin-induced nephrotoxicity by downregulating the MAPK and NF-κB pathways.
Kim IH; Kwon MJ; Jung JH; Nam TJ
Int J Mol Med; 2018 Jan; 41(1):511-520. PubMed ID: 29115386
[TBL] [Abstract][Full Text] [Related]
4. γ-secretase inhibitor DAPT mitigates cisplatin-induced acute kidney injury by suppressing Notch1 signaling.
Soni H; Matthews AT; Pallikkuth S; Gangaraju R; Adebiyi A
J Cell Mol Med; 2019 Jan; 23(1):260-270. PubMed ID: 30407728
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatocyte nuclear factor 1β contributes to cisplatin nephrotoxicity via regulation of nf-κb pathway.
Zhang Y; Hao J; Du Z; Li P; Hu J; Ruan M; Li S; Ma Y; Lou Q
J Cell Mol Med; 2021 Mar; 25(6):2861-2871. PubMed ID: 33512774
[TBL] [Abstract][Full Text] [Related]
6. Phlda3, a urine-detectable protein, causes p53 accumulation in renal tubular cells injured by cisplatin.
Lee CG; Kang YJ; Kim HS; Moon A; Kim SG
Cell Biol Toxicol; 2015 Apr; 31(2):121-30. PubMed ID: 25809501
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill.
Xie X; He G; Siddik ZH
Mol Pharmacol; 2020 Apr; 97(4):237-249. PubMed ID: 32063580
[TBL] [Abstract][Full Text] [Related]
8. Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure.
Su H; Ye C; Lei CT; Tang H; Zeng JY; Yi F; Zhang C
FASEB J; 2020 Jan; 34(1):1620-1636. PubMed ID: 31914692
[TBL] [Abstract][Full Text] [Related]
9. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.
Nozaki Y; Kinoshita K; Hino S; Yano T; Niki K; Hirooka Y; Kishimoto K; Funauchi M; Matsumura I
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F899-909. PubMed ID: 25651561
[TBL] [Abstract][Full Text] [Related]
10. Bibenzyl analogue DS-1 inhibits MDM2-mediated p53 degradation and sensitizes apoptosis in lung cancer cells.
Putri HE; Nutho B; Rungrotmongkol T; Sritularak B; Vinayanuwattikun C; Chanvorachote P
Phytomedicine; 2021 May; 85():153534. PubMed ID: 33773191
[TBL] [Abstract][Full Text] [Related]
11. Murine Double Minute-2 Inhibition Attenuates Cardiac Dysfunction and Fibrosis by Modulating NF-κB Pathway After Experimental Myocardial Infarction.
Zhao H; Shen R; Dong X; Shen Y
Inflammation; 2017 Feb; 40(1):232-239. PubMed ID: 27838797
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of Mdm2 inhibition in malignant germ cell tumours.
Bauer S; Mühlenberg T; Leahy M; Hoiczyk M; Gauler T; Schuler M; Looijenga L
Eur Urol; 2010 Apr; 57(4):679-87. PubMed ID: 19560254
[TBL] [Abstract][Full Text] [Related]
13. MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function.
Azmi AS; Aboukameel A; Banerjee S; Wang Z; Mohammad M; Wu J; Wang S; Yang D; Philip PA; Sarkar FH; Mohammad RM
Eur J Cancer; 2010 Apr; 46(6):1122-31. PubMed ID: 20156675
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling.
Al Fayi M; Otifi H; Alshyarba M; Dera AA; Rajagopalan P
J Drug Target; 2020 Nov; 28(9):913-922. PubMed ID: 31983246
[TBL] [Abstract][Full Text] [Related]
15. Polysulfide and Hydrogen Sulfide Ameliorate Cisplatin-Induced Nephrotoxicity and Renal Inflammation through Persulfidating STAT3 and IKKβ.
Sun HJ; Leng B; Wu ZY; Bian JS
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096924
[TBL] [Abstract][Full Text] [Related]
16. MDM2 inhibition improves cisplatin-induced renal injury in mice via inactivation of Notch/hes1 signaling pathway.
Luo X; Zhang L; Han GD; Lu P; Zhang Y
Hum Exp Toxicol; 2021 Feb; 40(2):369-379. PubMed ID: 32856486
[TBL] [Abstract][Full Text] [Related]
17. Urinary tubular protein-based biomarkers in the rodent model of cisplatin nephrotoxicity: a comparative analysis of serum creatinine, renal histology, and urinary KIM-1, NGAL, and NAG in the initiation, maintenance, and recovery phases of acute kidney injury.
Sinha V; Vence LM; Salahudeen AK
J Investig Med; 2013 Mar; 61(3):564-8. PubMed ID: 23360846
[TBL] [Abstract][Full Text] [Related]
18. Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling.
Huang YC; Tsai MS; Hsieh PC; Shih JH; Wang TS; Wang YC; Lin TH; Wang SH
Toxicol Appl Pharmacol; 2017 Aug; 329():128-139. PubMed ID: 28558962
[TBL] [Abstract][Full Text] [Related]
19. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
[TBL] [Abstract][Full Text] [Related]
20.
Zhang W; Hou J; Yan X; Leng J; Li R; Zhang J; Xing J; Chen C; Wang Z; Li W
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
